National Healthcare Quality Report, 2013
Chapter 2: Text Descriptions
Figure 2.1. Women who reported they had a mammogram within the past 2 years, by insurance (ages 50-64), 2000, 2003, 2005, 2008, and 2010, and activity limitation (ages 50-74), 2008 and 2010.
| Insurance | 2000 | 2003 | 2005 | 2008 | 2010 |
|---|---|---|---|---|---|
| Private | 83.7% | 82.5% | 79.1% | 79.0% | 80.1% |
| Public | 73.7% | 68.9% | 60.8% | 73.9% | 67.1% |
| Uninsured | 49.2% | 45.3% | 39.0% | 46.2% | 38.5% |
| Total | 77.2% | 75.7% | 72.0% | 73.7% | 72.4% |
| 2008 | 2010 | |
|---|---|---|
| Basic Limitations | 67.3% | 69.2% |
| Complex Limitations | 64.5% | 64.0% |
| Neither Limitation | 76.8% | 76.0% |
Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Health Interview Survey, 2000, 2003, 2005, 2008, and 2010.
Denominator: Civilian noninstitutionalized women ages 50-64 (left). Civilian noninstitutionalized women ages 50-74 (right).
Note: Rates are age adjusted to the 2000 U.S. standard population. Basic activity limitations include problems with mobility, self-care, domestic life, or activities that depend on sensory functioning. Complex activity limitations include limitations experienced in work or in community, social, and civic life. Data for activity limitations are not available for 2000, 2003, and 2005.
2008 Achievable Benchmark: 88%
Figure 2.2. Age-adjusted rate of advanced stage breast cancer per 100,000 women age 40 and over, by age, 2000-2009
| Year | 40-49 (per 100,000) | 50-64 (per 100,000) | 65+ (per 100,000) |
|---|---|---|---|
| 2000 | 62.0 | 106.1 | 122.8 |
| 2001 | 61.6 | 106.7 | 124.1 |
| 2002 | 60.0 | 105.4 | 122.8 |
| 2003 | 62.1 | 100.6 | 114.5 |
| 2004 | 62.6 | 100.5 | 120.7 |
| 2005 | 61.9 | 99.2 | 120.5 |
| 2006 | 62.5 | 98.7 | 121.6 |
| 2007 | 63.4 | 98.1 | 123.3 |
| 2008 | 62.4 | 98.7 | 123.4 |
| 2009 | 61.8 | 95.7 | 121.0 |
Source: Centers for Disease Control and Prevention and National Cancer Institute, National Program of Cancer Registries (NPCR), United States Cancer Statistics. Includes NPCR and National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registries meeting United States Cancer Statistics publication criteria for every year. Covers 90.1% of the total U.S. population. States excluded are Arkansas, District of Columbia, Mississippi, North Carolina, South Dakota, Tennessee, and Virginia.
Denominator: Women age 40 and over.
Note: For this measure, lower rates are better. Age adjusted to the 2000 U.S. standard population. Advanced stage breast cancer is defined as local stage with tumor size greater than 2 cm diameter, regional stage or distant stage.
Figure 2.3. Women with clinical Stage I-IIb breast cancer who received axillary node dissection or sentinel lymph node biopsy at the time of lumpectomy or mastectomy, by insurance status (under age 65) and age, 2004-2010
| Insurance Status | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|
| Total | 88.2% | 90.1% | 90.9% | 92.4% | 93.8% | 94.1% | 94.5% |
| Private | 93.4% | 94.7% | 95.1% | 95.7% | 96.1% | 96.1% | 96.7% |
| Public | 91.9% | 92.8% | 93.3% | 95.0% | 95.6% | 95.5% | 95.9% |
| Uninsured | 93.5% | 94.5% | 94.9% | 95.6% | 96.0% | 95.9% | 96.3% |
| < 40 | 92.4% | 94.2% | 93.8% | 95.3% | 95.3% | 95.8% | 96.1% |
| 40-49 | 93.3% | 94.0% | 94.5% | 95.6% | 96.2% | 95.8% | 96.4% |
| 50-59 | 93.5% | 94.9% | 95.1% | 95.8% | 95.9% | 96.1% | 96.6% |
| 60-69 | 92.8% | 94.0% | 94.4% | 95.1% | 96.0% | 96.2% | 96.5% |
| 70-79 | 85.7% | 88.5% | 90.1% | 91.7% | 93.6% | 94.3% | 94.8% |
| 80+ | 57.2% | 60.9% | 62.7% | 67.9% | 75.2% | 76.2% | 75.6% |
Source: Commission on Cancer, American College of Surgeons and American Cancer Society, National Cancer Data Base, 2004-2010.
Denominator: Women with Stage I-IIb breast cancer undergoing lumpectomy or mastectomy.
2008 Achievable Benchmark: 97%
Figure 2.4. Women under age 70 treated for breast cancer with breast-conserving surgery who received radiation therapy within 1 year of diagnosis, by insurance (under age 65) and age, 2004-2010
| Insurance | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|
| Private | 83.7% | 82.9% | 84.4% | 85.1% | 86.2% | 83.4% | 83.1% |
| Public | 77.5% | 77.7% | 79.1% | 80.1% | 80.4% | 77.9% | 77.1% |
| Uninsured | 81.8% | 82.1% | 83.3% | 83.7% | 86.3% | 82.3% | 80.6% |
| Total | 82.5% | 82.0% | 83.5% | 84.3% | 85.5% | 82.4% | 81.9% |
| <40 | 77.1% | 78.2% | 78.3% | 78.9% | 79.9% | 77.2% | 75.4% |
| 40-49 | 81.8% | 80.7% | 82.6% | 82.9% | 84.9% | 81.2% | 80.6% |
| 50-59 | 83.2% | 83.2% | 84.4% | 85.0% | 86.0% | 83.1% | 82.6% |
| 60-69 | 83.3% | 82.5% | 84.2% | 85.3% | 86.3% | 83.0% | 82.6% |
Source: Commission on Cancer, American College of Surgeons and American Cancer Society, National Cancer Data Base, 2004-2010.
Denominator: Women under age 70 undergoing breast-conserving surgery.
Note: Data for 2008 and 2009 may be lower due to the timing of data collected. Radiation can be administered 1 year from diagnosis, so registries may not complete radiation information at the time of case abstraction.
2008 Achievable Benchmark: 94%
Figure 2.5. Age-adjusted breast cancer deaths per 100, 000 women, by age (2000-2010) and residence location (2004-2010).
| Age | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total (per 100,000) | 26.8 | 26.0 | 25.6 | 25.3 | 24.4 | 24.1 | 23.5 | 22.9 | 22.5 | 22.3 | 22.1 |
| 18-44 (per 100,000) | 5.9 | 5.9 | 5.6 | 5.6 | 5.2 | 5.1 | 4.9 | 4.5 | 4.5 | 4.6 | 4.2 |
| 45-64 (per 100,000) | 43.5 | 42.6 | 41.4 | 41.2 | 40.3 | 39.6 | 38.7 | 37.3 | 36.6 | 36.3 | 35.7 |
| 65+ (per 100,000) | 120.2 | 115.9 | 116.1 | 114.3 | 110.9 | 109.9 | 107.6 | 106.9 | 104.8 | 102.7 | 103.7 |
| Residence Location | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|
| Large Central MSA (per 100,000) | 24.9 | 24.3 | 23.7 | 23.2 | 23 | 22.9 | 22.5 |
| Large Fringe MSA (per 100,000) | 25.0 | 24.5 | 23.7 | 23.4 | 22.8 | 22.6 | 22.3 |
| Medium MSA (per 100,000) | 24 | 23.5 | 23.3 | 22.1 | 22.1 | 21.9 | 22.0 |
| Small MSA (per 100,000) | 24.0 | 23.7 | 23.6 | 22.9 | 22.1 | 21.5 | 21.3 |
| Micropolitan (per 100,000) | 24.0 | 23.7 | 22.6 | 23.2 | 21.8 | 21.6 | 22.0 |
| Noncore (per 100,000) | 23.5 | 24.1 | 23.7 | 22.7 | 22.5 | 22.2 | 21.7 |
Key: MSA = metropolitan statistical area.
Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System-Mortality, 2000-2010.
Denominator: U.S. female population.
Note: For this measure, lower rates are better. Total rate is age adjusted to the 2000 U.S. standard population.
2008 Achievable Benchmark: 17 per 100,000
Figure 2.6. Adults who reported receiving a blood pressure measurement in the last 2 years and can state whether their blood pressure was normal or high, by race/ethnicity and activity limitations, 2008
| Activity Limitation | White | Black | Hispanic |
|---|---|---|---|
| Total | 93.6% | 93.5% | 89.0% |
| Basic Limitations | 95.3% | 94.9% | 89.8% |
| Complex Limitations | 95.0% | 95.5% | 92.6% |
| Neither Limitation | 93.4% | 93.3% | 88.5% |
Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Health Interview Survey, 2008.
Denominator: Civilian noninstitutionalized population age 18 and over.
Note: White and Black are non-Hispanic; Hispanic includes all races. Rates are age adjusted to the 2000 U.S. standard population. Basic activity limitations include problems with mobility, self-care, domestic life, or activities that depend on sensory functioning. Complex activity limitations include limitations experienced in work or in community, social, and civic life.
Figure 2.7. Inpatient deaths per 1,000 adult hospital admissions with heart attack, by expected payment source and sex, 2004-2010
| Payment Source / Sex | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|
| Private (per 1,000) | 73.4 | 71.6 | 69.1 | 63.5 | 60.6 | 53 | 49.9 |
| Medicare (per 1,000) | 82.2 | 76.2 | 71 | 65.4 | 57.3 | 52.9 | 50.2 |
| Medicaid (per 1,000) | 89.8 | 79.8 | 75.8 | 74.7 | 63.6 | 57.8 | 55.4 |
| Uninsured (per 1,000) | 97.3 | 96.2 | 89 | 88.1 | 84.1 | 75.5 | 76.1 |
| Total (per 1,000) | 81.7 | 76.3 | 71.6 | 66.1 | 58.8 | 54.1 | 51.4 |
| Male (per 1,000) | 73 | 69.6 | 62 | 59.7 | 52.9 | 48.9 | 46.1 |
| Female (per 1,000) | 100.4 | 92.4 | 85.7 | 77.1 | 69.5 | 61.3 | 58.5 |
Source: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project, Nationwide Inpatient Sample and AHRQ Quality Indicators, modified version 4.1, 2004-2010.
Denominator: Adults age 18 and over admitted to a non-Federal community hospital in the United States with acute myocardial infarction as principal discharge diagnosis.
Note: For this measure, lower rates are better. Rates are adjusted by age, major diagnostic category, all payer refined-diagnosis related group risk of mortality score, and transfers into the hospital.
2008 Achievable Benchmark: 48 per 1,000
Figure 2.8. Adult admissions for congestive heart failure per 100,000 population, by age and sex, 2004-2010
| Age / Sex | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|
| Total (per 100,000) | 440 | 421.9 | 414.2 | 382.4 | 369.7 | 361.7 | 332.3 |
| 18-44 (per 100,000) | 34.1 | 33 | 34.5 | 33.2 | 29.7 | 29.8 | 29.7 |
| 45-64 (per 100,000) | 307.8 | 283.2 | 285 | 269.1 | 251 | 256.1 | 245.5 |
| 65+ (per 100,000) | 2038 | 1981.7 | 1934.2 | 1781.2 | 1756.7 | 1693.5 | 1527.3 |
| Male (per 100,000) | 494.8 | 479.5 | 474 | 440.1 | 430.4 | 425 | 394.1 |
| Female (per 100,000) | 399.4 | 378.2 | 369.5 | 339.5 | 325.4 | 315.1 | 286.6 |
Source: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project, Nationwide Inpatient Sample and AHRQ Quality Indicators, modified version 4.1, 2004-2010.
Denominator: U.S. resident population age 18 and over.
Note: For this measure, lower rates are better. Age rates are adjusted by sex; sex rates are adjusted by age.
2008 Achievable Benchmark: 195 per 100,000
Figure 2.9. Total national costs of hospitalizations for congestive heart failure, 2000-2010
| Year | Costs in Billions |
|---|---|
| 2000 | 8.1 |
| 2001 | 8.4 |
| 2002 | 8.8 |
| 2003 | 8.7 |
| 2004 | 8.6 |
| 2005 | 8.2 |
| 2006 | 8.3 |
| 2007 | 7.7 |
| 2008 | 7.6 |
| 2009 | 7.5 |
| 2010 | 7.4 |
Source: Agency for Healthcare Research and Quality (AHRQ), Healthcare Cost and Utilization Project, Nationwide Inpatient Sample, and AHRQ Quality Indicators, modified version 4.1, 2000-2010.
Denominator: Civilian noninstitutionalized adults age 18 and over.
Note: For this measure, lower rates are better. Annual rates are adjusted for age and sex. Costs are adjusted for inflation and are represented in 2010 dollars.
Figure 2.10. New end stage renal disease patients age 18 and over who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy, by age and sex, 2005-2010
| Age / Sex | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|
| Total | 25.4% | 26.2% | 27.1% | 28.3% | 28.3% | 29.3% |
| 18-44 | 23% | 22.6% | 23.1% | 23.9% | 23.4% | 23.7% |
| 45-64 | 25.5% | 26% | 26.5% | 27.1% | 27.2% | 27.7% |
| 65-74 | 27% | 28.3% | 28.7% | 30.4% | 30.6% | 32% |
| 75+ | 25.2% | 26.6% | 28.4% | 30.3% | 30.3% | 31.9% |
| Male | 25.8% | 26.3% | 27.1% | 28.1% | 28% | 29.3% |
| Female | 26% | 26.2% | 27.1% | 28.6% | 28.6% | 29.2% |
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Renal Data System, 2005-2010.
Denominator: Denominator includes all new ESRD patients age 18 and over with valid CMS-2728 Medical Evidence form, and a nonmissing value for the question: did you see a nephrologist at all?
Numerator: Patients who saw a nephrologist at least 12 moonths prior to initiation of renal replacement therapy.
2010 Achievable Benchmark: 51%
Figure 2.11. End stage renal disease patients age 18 and over who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy, by State, United States, 2010
| State | Percent |
|---|---|
| District of Columbia | 14.8 |
| California | 17.1 |
| Maryland | 20.7 |
| Illinois | 20.9 |
| Nevada | 21.1 |
| Tennessee | 22.2 |
| Mississippi | 22.2 |
| Indiana | 22.5 |
| Kentucky | 22.8 |
| Oklahoma | 24.6 |
| West Virginia | 25.5 |
| Pennsylvania | 26 |
| Puerto Rico | 27.1 |
| New Mexico | 27.3 |
| Louisiana | 27.5 |
| Florida | 27.7 |
| Alabama | 27.9 |
| Arizona | 28.2 |
| Arkansas | 29.4 |
| Nebraska | 29.5 |
| New York | 29.7 |
| Georgia | 30.5 |
| Missouri | 30.7 |
| Ohio | 30.8 |
| Texas | 30.9 |
| Wyoming | 31.9 |
| Virginia | 32.0 |
| New Jersey | 32.7 |
| Kansas | 33.8 |
| South Carolina | 34.1 |
| Utah | 35.3 |
| North Carolina | 36.2 |
| Michigan | 37.7 |
| Colorado | 37.8 |
| Connecticut | 38.1 |
| Idaho | 38.6 |
| Iowa | 38.9 |
| Minnesota | 39.7 |
| Alaska | 42.9 |
| Rhode Island | 42.9 |
| Oregon | 43.3 |
| Washington | 44.2 |
| Massachusetts | 44.6 |
| New Hampshire | 45.5 |
| Delaware | 46.5 |
| South Dakota | 46.6 |
| Wisconsin | 47.1 |
| Vermont | 47.5 |
| Montana | 47.9 |
| Hawaii | 51.7 |
| Maine | 52.6 |
| North Dakota | 53.7 |
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, United States Renal Data System, 2010.
Denominator: New end stage renal disease patients age 18 and over.
Note: Data are not available for the U.S. territories, American Samoa, Guam, Northern Mariana Islands, or Virgin Islands because they do not meet the criteria for statistical reliability, data quality, or confidentiality.
Figure 2.12. Standardized mortality ratios on hemodialysis, by State or territory, 2010-2011
| State / Territory | Ratios |
|---|---|
| Montana | 0.84 |
| Virgin Islands | 0.85 |
| South Dakota | 0.85 |
| Maine | 0.86 |
| Massachusetts | 0.87 |
| Connecticut | 0.88 |
| Colorado | 0.88 |
| District of Columbia | 0.88 |
| Vermont | 0.89 |
| North Dakota | 0.9 |
| Oregon | 0.9 |
| Hawaii | 0.92 |
| Minnesota | 0.92 |
| New Mexico | 0.92 |
| Wisconsin | 0.93 |
| New Jersey | 0.94 |
| Delaware | 0.94 |
| Rhode Island | 0.94 |
| New Hampshire | 0.95 |
| Alaska | 0.95 |
| Washington | 0.95 |
| Wyoming | 0.96 |
| California | 0.96 |
| New York | 0.96 |
| Michigan | 0.97 |
| Tennessee | 0.98 |
| Illinois | 0.99 |
| Ohio | 0.99 |
| Indiana | 0.99 |
| Arizona | 1.00 |
| Pennsylvania | 1.00 |
| Nebraska | 1.00 |
| North Carolina | 1.00 |
| Utah | 1.01 |
| Oklahoma | 1.01 |
| Kansas | 1.02 |
| Iowa | 1.04 |
| Missouri | 1.04 |
| Texas | 1.05 |
| Nevada | 1.06 |
| Georgia | 1.06 |
| Mississippi | 1.08 |
| Maryland | 1.08 |
| Alabama | 1.09 |
| Virginia | 1.09 |
| Louisiana | 1.10 |
| South Carolina | 1.10 |
| Kentucky | 1.10 |
| Florida | 1.12 |
| Idaho | 1.12 |
| Arkansas | 1.13 |
| West Virginia | 1.19 |
| Northern Marianas | 1.30 |
| Puerto Rico | 1.58 |
| Guam | 1.97 |
Source: University of Michigan Kidney Epidemiology and Cost Center, 2010-2011 Dialysis Facility Report.
Denominator: Number of deaths that would be expected among Medicare dialysis patients (adult and pediatric) at the facility during the reporting period, given the patient mix at the facility, aggregated by State.
Note: For this measure, ratios for 2010 and 2011 are averaged. Lower ratios are better.
Figure 2.13. Dialysis patients under age 70 who were registered for transplantation within a year of ESRD initiation, by age and sex, 2001-2009
| Age / Sex | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 |
|---|---|---|---|---|---|---|---|---|---|
| Total | 14.3% | 14.5% | 14.7% | 15.4% | 15.9% | 17% | 17% | 17% | 17.4% |
| 0-19 | 41.5% | 43.1% | 47.4% | 44.9% | 48.8% | 50.4% | 50.1% | 48.9% | 46.2% |
| 20-39 | 26.7% | 27.3% | 25.5% | 26.6% | 25.9% | 27.9% | 26.6% | 27% | 26.8% |
| 40-59 | 16.2% | 15.8% | 16.1% | 16.6% | 17% | 17.8% | 18.1% | 17.5% | 18.3% |
| 60-69 | 6.8% | 7.6% | 8.1% | 9% | 9.8% | 10.9% | 11.1% | 11.8% | 12.2% |
| Total | 14.3% | 14.5% | 14.7% | 15.4% | 15.9% | 17% | 17% | 17% | 17.4% |
| Male | 15.2% | 15.9% | 15.9% | 16.6% | 17% | 18.1% | 18% | 17.9% | 18.4% |
| Female | 13.2% | 12.9% | 13.2% | 13.8% | 14.4% | 15.4% | 15.7% | 15.9% | 16% |
Source: National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Renal Data System, 2001-2009.
Denominator: New end stage renal disease patients (receiving hemodialysis or peritonial dialysis) in the given year who were under sge 70 and had a known State of residence in the 50 States or the District of Columbia.
Numerator: Patients who were either wait-listed or received a deceased-donor kidney within 1 year of their ESRD initiation date.
Note: Patients who received a transplate at any time from a live donor or residing in American territories were excluded. Percentages are estimated using he Kaplan-Meier methodology.
2008 Achievable Benchmark: 27%
Figure 2.14. Adults age 40 and over with diagnosed diabetes who reported receiving four recommended services for diabetes in the calendar year (2+ hemoglobin A1c tests, foot exam, dilated eye exam, and flu shot), by residence location and age, 2008-2010
| 2008 | 2009 | 2010 | |
|---|---|---|---|
| Large Central MSA | 18.6% | 20.9% | 26.3% |
| Large Fringe MSA | 21.1% | 27.9% | 22.4% |
| Medium MSA | 20.0% | 26.8% | 26.4% |
| Small MSA | 22.3% | 22.6% | 26.3% |
| Micropolitan | 27.5% | 19.4% | 19.9% |
| Noncore | NA | 13.6% | 24.1% |
| Total | 21.0% | 23.2% | 24.6% |
| 40-59 | 16.0% | 18.4% | 19.0% |
| 60+ | 29.0% | 30.9% | 33.5% |
Key: MSA = metropolitan statistical area.
Source: Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey, 2008-2010.
Denominator: Civilian noninstitutionalized population with diagnosed diabetes, age 40 and over.
Note: Data include people with both type 1 and type 2 diabetes. Rates are age adjusted to the 2000 U.S. standard population using two age groups: 40-59 and 60 and over. The noncore residence location sample size in 2008 did not meet requirements for statistical reliability, data quality, or confidentiality and is not included.
Figure 2.15. Hospital admissions for uncontrolled diabetes without complications per 100,000 population, age 18 and over, by age and residence location, 2004-2010
| Age | 2004 | 2005 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|
| Total (per 100,000) | 22.0 | 20.4 | 21.1 | 22.1 | 22.0 | 19.2 |
| 18-44 (per 100,000) | 11.5 | 11.1 | 11.8 | 11.8 | 11.7 | 10.1 |
| 45-64 (per 100,000) | 28.5 | 27.0 | 27.5 | 29.3 | 29.4 | 25.9 |
| 65+ (per 100,000) | 43.9 | 38.1 | 38.5 | 41.1 | 41.3 | 35.4 |
| Residence Location | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|
| Large Central MSA (per 100,000) | 26.5 | 25.8 | 30.1 | 27.3 | 29.5 | 30.4 | 22.1 |
| Large Fringe MSA (per 100,000) | 17.6 | 16.1 | 16.6 | 17.6 | 19.2 | 18.2 | 19.5 |
| Medium MSA (per 100,000) | 15.1 | 16.0 | 14.3 | 15.0 | 16.6 | 16.1 | 14.9 |
| Small MSA (per 100,000) | 19.0 | 13.7 | 14.8 | 17.5 | 16.8 | 16.4 | 17.3 |
| Micropolitan (per 100,000) | 27.9 | 23.2 | 24.7 | 22.8 | 21.7 | 22.2 | 16.7 |
| Noncore (per 100,000) | 34.4 | 31.7 | 29.9 | 28.2 | 26.7 | 27.2 | 25.3 |
Key: MSA = metropolitan statistical area.
Source: Agency for Healthcare Research and Quality (AHRQ), Healthcare Cost and Utilization Project, Nationwide Inpatient Sample and AHRQ Quality Indicators, version 4.1, 2004-2010.
Denominator: U.S. resident population age 18 and over.
Note: For this measure, lower rates are better.
2008 Achievable Benchmark: 5 per 100,000
Figure 2.16. Adults age 20 and over with end stage renal disease due to diabetes, per million population, by age and sex, 2004-2010
| Age / Sex | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|
| Total (per million) | 156 | 156.1 | 160.3 | 155.2 | 153.4 | 154.1 | 151.7 |
| 20-44 (per million) | 37.1 | 38.1 | 41.7 | 41.1 | 41.3 | 43.7 | 43.6 |
| 45-64 (per million) | 328.1 | 328.4 | 331.9 | 317.5 | 316.7 | 314.2 | 297.6 |
| 65-74 (per million) | 735.2 | 724.5 | 739 | 715.3 | 692.5 | 692.2 | 670 |
| 75+ (per million) | 575 | 580.7 | 598.4 | 597.2 | 586.9 | 592.2 | 616.8 |
| Male (per million) | 182 | 183.5 | 189.4 | 185.4 | 184.5 | 186.9 | 184 |
| Female (per million) | 135 | 133.9 | 136.5 | 131 | 128.3 | 127.7 | 125.3 |
Source: National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Renal Data System, 2004-2010.
Denominator: U.S. resident population.
Note: For this measure, lower rates are better. Rates are adjusted by age, sex, race, and interactions of age, sex, and race. When reporting is by age, the adjustment is by sex, race, and interactions of sex and race. When reporting is by sex, the adjustment is by age, race, and interactions of age and race.
2010 Achievable Benchmark: 71 per million
Figure 2.17. New AIDS cases per 100,000 population age 13 and over, by age and sex, 2000-2010
| Age / Sex | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total (per 100,000) | 17.4 | 16.7 | 16.5 | 16.6 | 15.9 | 15 | 14.2 | 13.6 | 13 | 12.3 | 11.5 |
| 13-17 (per 100,000) | 0.9 | 0.9 | 1 | 1 | 1 | 1.1 | 1 | 1.1 | 1 | 0.8 | 0.8 |
| 18-44 (per 100,000) | 25.2 | 24 | 23.7 | 23.8 | 22.5 | 20.9 | 19.6 | 18.6 | 17.7 | 16.6 | 15.7 |
| 45-64 (per 100,000) | 17.1 | 16.9 | 17.1 | 17.2 | 16.8 | 16.4 | 15.7 | 15.3 | 14.9 | 14.4 | 13.2 |
| 65+ (per 100,000) | 2.1 | 2.1 | 2 | 2.2 | 2.2 | 2 | 2.2 | 2 | 2 | 2 | 1.9 |
| Male (per 100,000) | 26.5 | 25.3 | 25.1 | 25 | 23.9 | 22.5 | 21.3 | 20.2 | 19.6 | 18.7 | 17.6 |
| Female (per 100,000) | 8.8 | 8.6 | 8.4 | 8.7 | 8.3 | 7.7 | 7.4 | 7.2 | 6.7 | 6.2 | 5.6 |
Source: Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, HIV/AIDS Surveillance System, 2000-2010.
Denominator: U.S. population age 13 and over.
Note: For this measure, lower rates are better.
2010 Achievable Benchmark: 2.8 per 100,000
Figure 2.18. HIV patients who received recommended care, by age and expected payment source, 2010
| 2 or More Outpatient Visits | 2 or More CD4 Tests | HAART | PCP Prophylaxis | MAC Prophylaxis | |
|---|---|---|---|---|---|
| Total | 89.5% | 81.2% | 94.6% | 93.6% | 91.4% |
| 18-44 | 87.1% | 78.4% | 93.7% | 94.2% | 91.4% |
| 45+ | 91.3% | 83.3% | 95.3% | 93.1% | 91.5% |
| Private | 88.2% | 76.7% | 93.8% | 89.3% | 95.9% |
| Medicaid | 93% | 82.2% | 95.5% | 93.3% | 89.6% |
| Medicare / Dual Eligible | 91.5% | 83.6% | 95% | 94.7% | 88.5% |
Key: HAART = highly active antriretroviral therapy; PCP = Pneumocystis pneumonia; MAC = Mycobacterium avium complex.
Source: Agency for Healthcare Research and Quality, HIV Research Network, 2010.
Note: For HAART measure, adult HIV patients had to be enrolled in an HIV Network clinic, receive at least one CD4 test, and have at least one outpatient visit in addition to having at least one CD4 test result of 350 or less.
Figure 2.19. Adult HIV patients with viral suppression for first test in the year, by age and insurance, 2008-2010
| 2008 | 2009 | 2010 | |
|---|---|---|---|
| Total | 57.7% | 68.5% | 73% |
| 18-44 | 50.2% | 61.5% | 65.9% |
| 45+ | 64.7% | 73.8% | 78.3% |
| Private | 65.8% | 77.2% | 77.6% |
| Medicaid | 55% | 63.3% | 68.8% |
| Medicare / Dual Eligible | 63.8% | 75.2% | 77% |
Source: Agency for Healthcare Research and Quality, HIV Research Network, 2008-2010.
Denominator: Includes adult HIV patients enrolled in an HIV Research Network medical practice prior to the year. Patients who died, did not have an outpatient visit, or did not have a CD4 test in the year are excluded.
Note: Viral load suppression means HIV RNA <400 copies/mL.
Figure 2.20. HIV infection deaths per 100,000 population, by sex and age, 2000-2010
| Sex / Age | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Male (per 100,000) | 7.9 | 7.5 | 7.4 | 7.1 | 6.6 | 6.2 | 5.9 | 5.4 | 4.8 | 4.4 | 3.8 |
| Female (per 100,000) | 2.5 | 2.5 | 2.5 | 2.4 | 2.4 | 2.3 | 2.2 | 2.1 | 1.9 | 1.7 | 1.4 |
| Total (per 100,000) | 5.2 | 5 | 4.9 | 4.7 | 4.5 | 4.2 | 4 | 3.7 | 3.3 | 3 | 2.6 |
| 18-44 (per 100,000) | 7.6 | 7.3 | 6.8 | 6.3 | 5.7 | 5.1 | 4.7 | 4.3 | 3.5 | 3 | 2.5 |
| 45-64 (per 100,000) | 8.7 | 8.4 | 8.7 | 8.7 | 8.5 | 8.4 | 8.1 | 7.7 | 7.2 | 6.6 | 6.1 |
| 65+ (per 100,000) | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.6 | 1.5 | 1.7 | 1.8 | 1.6 |
Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System-Mortality, 2004-2010.
Denominator: U.S. population.
Note: For this measure, lower rates are better. Rates are age adjusted to the 2000 U.S. standard population. Age data are unadjusted. Respondents for which age is not reported are not included in the age adjustment calculations and are excluded from numerators.
2008 Achievable Benchmark: 0.9 per 100,000
Figure 2.21. HIV clients in Ryan White-funded care who were virally suppressed (most recent HIV RNA <200 copies/mL), by current gender identity and health insurance, 2010
| Percent | |
|---|---|
| Total | 69.5 |
| Male | 70.9 |
| Female | 66.3 |
| Transgender | 61.5 |
| Private | 76.9 |
| Medicare | 76.8 |
| Medicaid | 64.6 |
| No Insurance | 65.4 |
Source: Health Resources and Services Administration, 2010.
Denominator: HIV-positive clients all ages who received Ryan White-funded HIV care during the year and had visit date and viral load data available. Clients with missing viral load data are excluded.
Figure 2.22. HIV clients in Ryan White-funded care who were retained in HIV care (at least 2 ambulatory visits at least 90 days apart), by gender identity and insurance, 2010
| Percent | |
|---|---|
| Total | 79.7 |
| Male | 80.2 |
| Female | 78.6 |
| Transgender | 77.7 |
| Private | 78.7 |
| Medicare | 82.5 |
| Medicaid | 81.3 |
| No Insurance | 76.1 |
Source: Health Resources and Services Administration, 2010.
Denominator: Total estimated number of HIV-positive clients all ages who received at least one Ryan White-funded care visit during the year and have visit dates available.
Figure 2.23. Adults with a major depressive episode in the past year who received treatment for depression in the past year, by sex, 2008-2011
| Sex | 2008 | 2009 | 2010 | 2011 |
|---|---|---|---|---|
| Total (adults, age 18 and older) | 68.3% | 64.4% | 68.2% | 68.1% |
| Male | 60.9% | 59.0% | 59.8% | 61.0% |
| Female | 72.1% | 67.4% | 72.9% | 71.8% |
Source: Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health, 2008-2011.
Denominator: Adults age 18 and over with a major depressive episode in the past year.
Note: Major depressive episode is defined as a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of the symptoms of depression described in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders. Treatment for depression is defined as seeing or talking to a medical doctor or other professional or using prescription medication in the past year for depression.
Figure 2.24. Adults and adolescents with a major depressive episode in the past year who received treatment for depression in the past year, by sex, 2008-2011
| Sex | 2008 | 2009 | 2010 | 2011 |
|---|---|---|---|---|
| Total (adolescents, ages 12-17) | 37.7% | 34.7% | 37.8% | 38.4% |
| Male | 33.8% | 29.3% | 32.0% | 35.3% |
| Female | 39.2% | 37.0% | 40.1% | 39.5% |
Source: Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health, 2008-2011.
Denominator: Adolescents ages 12-17 with a major depressive episode in the past year.
Note: Major depressive episode is defined as a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of the symptoms of depression described in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders. Treatment for depression is defined as seeing or talking to a medical doctor or other professional or using prescription medication in the past year for depression.
Figure 2.25. Suicide deaths per 100,000 population age 12 and over, by age and residence location, 2008-2010.
| 2008 | 2009 | 2010 | |
|---|---|---|---|
| Total (per 100,000) | 14 | 14.2 | 14.6 |
| 12-17 (per 100,000) | 3.7 | 4 | 3.8 |
| 18-44 (per 100,000) | 13.8 | 13.8 | 14.3 |
| 45-64 (per 100,000) | 17.5 | 17.9 | 18.6 |
| 65+ (per 100,000) | 14.8 | 14.8 | 14.9 |
| Large Central MSA (per 100,000) | 12.3 | 12.1 | 12.3 |
| Large Fringe MSA (per 100,000) | 12.7 | 12.9 | 13.5 |
| Medium MSA (per 100,000) | 14.8 | 14.9 | 15.4 |
| Small MSA (per 100,000) | 15.7 | 16.3 | 16.6 |
| Micropolitan (per 100,000) | 16.9 | 17.6 | 17.8 |
| Noncore (per 100,000) | 18.4 | 18.8 | 20 |
Key: MSA = metropolitan statistical area.
Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System-Mortality, 2008-2010.
Note: For this measure, lower rates are better. Estimates are age adjusted to the 2000 U.S. standard population.
2008 Achievable Benchmark: 9 per 100,000
Figure 2.26. People age 12 and over who needed treatment for illicit drug use or an alcohol problem and who received such treatment at a specialty facility in the last 12 months, by age and education, 2008-2011
| 2008 | 2009 | 2010 | 2011 | |
|---|---|---|---|---|
| Total | 9.9% | 10.7% | 11.2% | 10.8% |
| 12-17 | 7.4% | 8.3% | 7.6% | 8.4% |
| 18-44 | 9.4% | 10.7% | 10.4% | 10.3% |
| 45-64 | 12.4% | 12% | 16.2% | 13.7% |
| <High School | 17% | 13.9% | 16.6% | 19.6% |
| High School Grad | 11.1% | 13.5% | 13.5% | 11.1% |
| Any College | 7.2% | 8.2% | 8.7% | 8.2% |
Source: Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health, 2008-2011.
Denominator: Civilian noninstitutionalized population age 12 and over who needed treatment for any illicit drug use or an alcohol problem.
Note: Total includes people age 65 and over, but data were not statistically reliable enough to produce specific estimates for this group. Treatment refers to treatment at a specialty facility, such as a drug and alcohol inpatient and/or outpatient rehabilitation facility, inpatient hospital setting, or mental health center.
2011 Achievable Benchmark: 15%
Figure 2.27. People age 12 and over treated for substance abuse who completed treatment course, by age and sex, 2005-2010
| Age / Sex | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|
| Total | 45% | 47.5% | 45.1% | 46.6% | 46.7% | 44.1% |
| 12-17 | 41.3% | 42.6% | 40.1% | 41% | 40.1% | 38.7% |
| 20-39 | 42.7% | 45.2% | 43.2% | 44.9% | 44.4% | 41.7% |
| 40+ | 49.4% | 52% | 49.4% | 50.8% | 51.9% | 49.3% |
| Male | 47.1% | 49.3% | 47.1% | 48.5% | 48.8% | 46.3% |
| Female | 40.4% | 43.5% | 41% | 42.6% | 42.1% | 39.8% |
Source: Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set, Discharge Data Set, 2005-2010.
Denominator: Discharges age 12 and over from publicly funded substance abuse treatment facilities.
2008 Achievable Benchmark: 74%
Figure 2.28. Adults with doctor-diagnosed arthritis who reported they had effective, evidence-based arthritis education as an integral part of the management of their condition, by education and activity limitations, 2009
| Percent | |
|---|---|
| Total | 11.2 |
| < High School | 9.7 |
| High School Grad | 8.8 |
| Any College | 13 |
| Basic Limitations | 14.7 |
| Complex Limitations | 15.1 |
| Neither Limitation | 9.1 |
Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Health Interview Survey, 2009.
Denominator: Civilian noninstitutionalized adults with doctor-diagnosed arthritis.
Note: Estimates are age adjusted to the 2000 U.S. standard population. Basic activity limitations include problems with mobility, self-care, domestic life, or activities that depend on sensory functioning. Complex activity limitations include limitations experienced in work or in community, social, and civic life.
Figure 2.29. Adults with doctor-diagnosed arthritis who reported they received health care provider counseling about physical activity or exercise, by income and activity limitation, 2009
| Percent | |
|---|---|
| Total | 57.2 |
| Poor | 56.4 |
| Low Income | 52.6 |
| Middle Income | 56.9 |
| High Income | 61.1 |
| Basic Limitations | 64.5 |
| Complex Limitations | 63.6 |
| Neither Limitation | 53.3 |
Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Health Interview Survey, 2009.
Denominator: Civilian noninstitutionalized adults with doctor-diagnosed arthritis.
Note: Estimates are age adjusted to the 2000 U.S. standard population. Basic activity limitations include problems with mobility, self-care, domestic life, or activities that depend on sensory functioning. Complex activity limitations include limitations experienced in work or in community, social, and civic life.
Figure 2.30. Overweight and obese adults with doctor-diagnosed arthritis who reported they received health care provider counseling about weight reduction, by insurance (under age 65) and activity limitation, 2009
| Percent | |
|---|---|
| Total | 42.1 |
| Private | 42.7 |
| Public | 47.1 |
| Uninsured | 38.5 |
| Basic Limitations | 52.3 |
| Complex Limitations | 48.8 |
| Neither Limitation | 36.1 |
Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Health Interview Survey, 2009.
Note: Estimates are age adjusted to the 2000 U.S. standard population. Basic activity limitations include problems with mobility, self-care, domestic life, or activities that depend on sensory functioning. Complex activity limitations include limitations experienced in work or in community, social, and civic life. People were considered to have doctor-diagnosed arthritis if they answered yes to "Have you ever been told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?" For both men and women, overweight is BMI ≥25 to <30; obese is BMI ≥30.
Denominator: Civilian noninstitutionalized overweight and obese adults with doctor-diagnosed arthritis.
Figure 2.31. Adults age 65 and over who reported ever receiving pneumococcal immunization, by activity limitation and residence location, 2006-2011
| 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | |
|---|---|---|---|---|---|---|
| Basic Limitations | 63.1% | 64.7% | 65.5% | 67.6% | 63.9% | 66.9% |
| Complex Limitations | 58% | 60.8% | 63.7% | 64.2% | 64.9% | 66.1% |
| Neither Limitation | 54.4% | 51.4% | 58.3% | 57.5% | 55.8% | 58.5% |
| Large Central MSA | 49.4% | 47.6% | 52.3% | 56% | 51.4% | 57.9% |
| Large Fringe MSA | 60% | 59.9% | 61.2% | 59.7% | 61.7% | 64.5% |
| Medium MSA | 59.5% | 58.2% | 63.8% | 63.8% | 64.4% | 65.2% |
| Small MSA | 61.2% | 65.9% | 60.6% | 65.2% | 60% | 62.2% |
| Micropolitan | 57.5% | 62.4% | 63.8% | 62.8% | 64.4% | 65.5% |
| Noncore | 62.2% | 60.9% | 63.9% | 64.3% | 63.6% | 64.4% |
Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Health Interview Survey, 2006-2011.
Key: MSA = metropolitan statistical area.
Note: Age adjusted to the 2000 U.S. standard population. Basic activity limitations include problems with mobility, self-care, domestic life, or activities that depend on sensory functioning. Complex activity limitations include limitations experienced in work or in community, social, and civic life. Benchmark is derived from the Behavioral Risk Factor Surveillance System (BRFSS); see Chapter 1, Introduction and Methods, for details.
Denominator: Civilian noninstitutionalized population age 65 and over.
2008 Achievable Benchmark: 67%
Figure 2.32. State variation: Adults age 65 and over who reported ever receiving pneumococcal immunization, 2010
| Lowest Quality Quartile | Second Quartile | Third Quartile | Highest Quality Quartile |
|---|---|---|---|
| Alabama | Alaska | Connecticut | Arizona |
| California | Arkansas | Delaware | Colorado |
| Georgia | Kansas | Florida | Maine |
| Hawaii | Louisiana | Indiana | Missouri |
| Idaho | Michigan | Iowa | Montana |
| Illinois | Mississippi | Massachusetts | New Hampshire |
| Kentucky | Nevada | Minnesota | North Carolina |
| Maryland | New Mexico | Nebraska | Oklahoma |
| New Jersey | Ohio | North Dakota | Oregon |
| New York | South Dakota | Pennsylvania | Vermont |
| Tennessee | Texas | Rhode Island | Virginia |
| West Virginia | Utah | South Carolina | Washington |
| NA | NA | Wyoming | Wisconsin |
Source: Centers for Disease Control and Prevention, Behavioral Risk Factor Surveillance System, 2010.
Key: Lowest Quality Quartile identifies States with the lowest rates of pneumococcal immunization; Highest Quality Quartile identifies States with the highest rates of pneumococcal immunization.
Figure 2.33. Hospital patients age 50 and over with pneumonia who received influenza immunization status assessment or provision, by age and sex, 2005-2011
| 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | |
|---|---|---|---|---|---|---|---|
| 50-64 | 47.2% | 62% | 73.8% | 80.8% | 87.2% | 90.4% | 92.6% |
| 65-74 | 57% | 70% | 79.7% | 85.6% | 90.8% | 92.3% | 94.3% |
| 75-84 | 59% | 71.5% | 81.1% | 86.8% | 91.8% | 93% | 95% |
| 85+ | 56.1% | 70% | 80.1% | 85.8% | 91.2% | 92.6% | 94.7% |
| Total | 55.2% | 68.5% | 78.7% | 84.7% | 90.2% | 92.1% | 94.1% |
| Male | 55.4% | 68.2% | 78.2% | 84.4% | 89.9% | 91.8% | 93.9% |
| Female | 55.1% | 68.9% | 79.1% | 85% | 90.4% | 92.3% | 94.2% |
Source: Centers for Medicare & Medicaid Services, Medicare Quality Improvement Organization Program, 2005-2011.
Denominator: Patients age 50 and over discharged October-February with a principal discharge diagnosis of pneumonia or a principal discharge diagnosis of either septicemia or respiratory failure and secondary diagnosis of pneumonia.
2011 Achievable Benchmark: 97%
Figure 2.34. Long-stay nursing home residents who were assessed and given influenza and pneumococcal immunization, by age and sex, 2011
| Influenza | Pneumococcal | |
|---|---|---|
| Total | 89.5% | 93.3% |
| 0-64 | 87.8% | 89.4% |
| 65-74 | 88.5% | 92.2% |
| 75-84 | 89.4% | 93.5% |
| 85+ | 90.5% | 94.8% |
| Male | 89.1% | 92.1% |
| Female | 89.7% | 93.9% |
Source: Centers for Medicare & Medicaid Services, Minimum Data Set, 2011. Data are from the third quarter of each calendar year.
Denominator: All long-stay residents in Medicare- or Medicaid-certified nursing home facilities.
Figure 2.35. Patients with tuberculosis who completed a curative course of treatment within 1 year of initiation of treatment, by age and sex, 2000-2009
| 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0-17 | 89.8% | 88.2% | 89.7% | 90.4% | 90.1% | 91.4% | 92.0% | 91.8% | 92.3% | 92.2% |
| 18-44 | 78.2% | 78.9% | 79.7% | 80.5% | 80.9% | 82.2% | 82.3% | 83.3% | 84.0% | 85.1% |
| 45-64 | 80.4% | 80.5% | 81.0% | 81.2% | 81.6% | 81.9% | 83.4% | 84.2% | 84.3% | 86.5% |
| 65+ | 81.1% | 81.4% | 79.6% | 82.4% | 83.4% | 81.6% | 83.0% | 83.5% | 83.9% | 85.0% |
| Total | 80.2% | 80.5% | 80.9% | 81.8% | 82.3% | 82.8% | 83.5% | 84.3% | 84.7% | 86.1% |
| Male | 80.1% | 79.8% | 80.0% | 81.3% | 80.8% | 82.0% | 82.2% | 83.5% | 84.0% | 85.2% |
| Female | 80.4% | 81.8% | 82.3% | 82.7% | 84.6% | 84.1% | 85.5% | 85.6% | 85.9% | 87.3% |
Source: Centers for Disease Control and Prevention, National Tuberculosis Surveillance System, 2000-2009.
Denominator: U.S. civilian noninstitutionalized population treated for tuberculosis.
2008 Achievable Benchmark: 94%
Figure 2.36. People with current asthma who reported taking preventive asthma medicine daily or almost daily, by insurance and age, 2003-2010
| 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
|---|---|---|---|---|---|---|---|---|
| Private | 29.8% | 29.9% | 31.6% | 29.1% | 28.6% | 24.9% | 24.1% | 25% |
| Public | 29.5% | 27.2% | 29.1% | 30.2% | 26.2% | 23.1% | 22.8% | 24.5% |
| Uninsured | 16.7% | 15.5% | 13.5% | 17.4% | 13.4% | 14.9% | 9.6% | 15.6% |
| Total | 29.6% | 29.7% | 31.2% | 30.9% | 28.3% | 25.9% | 25.1% | 26.5% |
| 0-17 | 28.4% | 32.8% | 30.6% | 31.2% | 29.7% | 24.2% | 23.4% | 25.6% |
| 18-44 | 21.4% | 20.5% | 23.1% | 23.7% | 19.9% | 16.7% | 16.5% | 18.4% |
| 45-64 | 38.7% | 35.6% | 40.7% | 33.8% | 32.9% | 32.4% | 30.6% | 32.6% |
| 65+ | 42% | 41.8% | 41% | 47.6% | 43.6% | 46.3% | 45.9% | 43.2% |
Source: Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey, 2003-2010.
Note: Age adjusted to the 2000 U.S. standard population using four age groups: 0-17, 18-44, 45-64, and 65 and over. People with current asthma report that they still have asthma or had an asthma attack in the last 12 months. Insurance groups presented are for patients under age 65.
Denominator: Civilian noninstitutionalized population with current asthma.
Figure 2.37. People with current asthma who received written asthma management plans from their health provider, by age and family income, 2008
| Age | Total | Poor | Low Income | Middle Income | High Income |
|---|---|---|---|---|---|
| 0-17 | 44.3% | 34.1% | 42.2% | 49.9% | 49.8% |
| 18-44 | 29.8% | 29.0% | 30.8% | 32.1% | 27.6% |
| 45-64 | 31.9% | 29.2% | 31.3% | 31.3% | 27.6% |
| 65+ | 26.1% | 30.6% | 22.7% | 24.9% | 29.5% |
Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Health Interview Survey, 2008.
Denominator: Civilian noninstitutionalized population with current asthma.
Page originally created May 2014
The information on this page is archived and provided for reference purposes only.
5600 Fishers Lane Rockville, MD 20857